Pyxis Oncology is trading 5.41% up now at $3.76, with no clear catalyst identified.
- No new company-specific announcement was identified on September 4, 2026; the latest update concerns upcoming investor conferences.
- The previously reported 39.2 million-share resale filing was dated August 20, not September 4.
- The broader market is mixed, providing no clear macro or sector catalyst.